'Current Controversies' Topic of Internal Medicine Grand Rounds March 16
Published March 2011
The Department of Internal Medicine is sponsoring a special themed medical grand rounds, "Current Controversies in Clinical Medicine – Anti-angiogenics in metastatic breast cancer," from noon to 1 p.m. Wednesday, March 16, in Medical Sciences Building Room 7051.
At this "Current Controversies in Clinical Medicine" event, audience members will have the opportunity to participate in a discussion about a controversy that has been raging in the media during the past two months relating to the use of bevacizumab (Avastin) in metastatic breast cancer.
• Olivier Rixe, MD, PhD, professor of clinical medicine, division of hematology oncology, will discuss the principles behind anti-angiogenic therapies and their activities in several different types of cancer.
• Mahmoud Charif, MD, assistant professor of clinical medicine, division of hematology oncology, will then discuss the data that led to the approval and later disapproval of bevacizumab by the FDA.
• George Atweh, MD, director of the division of hematology oncology and UC Cancer Institute, will talk about other targeted therapies that have had a dramatic impact on the outcome of patients with other types of cancer.
• Frank Putnam, MD, professor of pediatrics and psychiatry and director of the Mayerson Center for Safe & Healthy Children at Cincinnati Children's Hospital Medical Center, will lead a general discussion of the ethics, economics and the choices we have to make as a society when we use extremely expensive new drugs that result in a modest improvement in survival of patients with cancer.
For more information, contact Mary Rich at email@example.com or (513) 245-3425.